RATTOTTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 536
EU - Europa 298
AS - Asia 183
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.020
Nazione #
US - Stati Uniti d'America 534
IE - Irlanda 153
CN - Cina 147
FI - Finlandia 42
IT - Italia 27
DE - Germania 23
SG - Singapore 23
UA - Ucraina 16
BE - Belgio 10
IN - India 10
GB - Regno Unito 8
SE - Svezia 7
FR - Francia 6
RU - Federazione Russa 3
CA - Canada 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
JP - Giappone 1
MY - Malesia 1
PT - Portogallo 1
TR - Turchia 1
Totale 1.020
Città #
Dublin 153
Chandler 129
Ashburn 42
Boardman 42
Ann Arbor 37
Nanjing 34
Jacksonville 29
Helsinki 26
Beijing 23
Wilmington 23
Princeton 21
Lawrence 20
Medford 16
New York 16
Shanghai 15
Singapore 14
Nanchang 13
Brussels 10
Changsha 10
Pune 9
Hebei 8
Los Angeles 8
Shenyang 8
Woodbridge 8
Falls Church 6
Jiaxing 6
Tianjin 5
Varese 5
Falkenstein 4
Seattle 4
Washington 4
Guangzhou 3
Milan 3
Norwalk 3
Pavia 3
Redwood City 3
Zhengzhou 3
Chicago 2
Fairfield 2
Jinan 2
Paratico 2
Altoona 1
Auburn Hills 1
Baoding 1
Baotou 1
Berlin 1
Cangzhou 1
Chengdu 1
Dearborn 1
Des Moines 1
Houston 1
Lanzhou 1
Longyan 1
Paris 1
Prague 1
Saint Petersburg 1
San Jose 1
Santa Clara 1
Selangor 1
Shijiazhuang 1
St Petersburg 1
Tokyo 1
Tomsk 1
Toronto 1
Wuhan 1
Xiangtan 1
Totale 799
Nome #
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 93
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1. 81
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 71
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 68
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 65
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers 62
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 56
Antiviral therapies for managing viral hepatitis in lymphoma patients 52
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas 50
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 48
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 48
Mantle cell lymphoma of mucosa-associated lymphoid tissue: A european mantle cell lymphoma network study 43
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders 41
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis 37
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 37
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network 36
HCV infection and non-Hodgkin lymphomas: an evolving story 35
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network 34
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL) 33
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study 32
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis 25
Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy 19
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study 7
Totale 1.073
Categoria #
all - tutte 5.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 2 4 6 6 0 22 7 4
2020/202189 4 5 2 3 4 23 2 19 9 6 8 4
2021/2022105 1 3 1 0 6 7 1 9 7 3 14 53
2022/2023386 26 43 3 22 31 37 0 16 184 0 14 10
2023/2024207 31 35 8 6 15 49 6 14 1 9 16 17
2024/202561 11 26 11 10 3 0 0 0 0 0 0 0
Totale 1.073